Botkin.AI logo — AI-based platform for medical images processing and analysis

Botkin.AI

AI-based platform for medical images processing and analysis

Founded 2015 Russia Moscow, Russia 10 employees Series B Total: $161.70M AI, Health Care

General Information

Company Name Botkin.AI
Founded Year 2015
Location Russia Moscow, Russia
Employees 10
Industries AI, Health Care
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Botkin.AI. To contact Botkin.AI, visit botkin.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Botkin.AI

Botkin.AI is an innovative player within the AI and Health Care industries, offering an AI-based platform for medical images processing and analysis. Founded in 2015 and headquartered in Russia, this company targets the transformation of medical imaging by employing cutting-edge artificial intelligence technologies. The platform boasts features such as mathematical models for image analysis, a multimodal DICOM Viewer, and tools for visualizing pathology analyses, enhancing the interaction between radiologists and AI tools.

The company’s last known funding activity was a Series B investment amounting to RUB160.00M on 23 December 2020. This round was backed by established investors, including RBV Capital, Unicorn Capital Partners, Primer Capital, and Tashir Medica. Given its robust AI-driven solutions and the support from reputable investors, Botkin.AI is poised for growth, appealing to investors interested in the intersection of technology and health care.

Taxonomy: AI-based medical imaging, medical image processing, radiology solutions, tumor diagnosis, deep machine learning, pathology analysis, DICOM viewer, image markup tools, radiogram analysis, clinical data processing, radiologist-AI integration, image analysis software

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series B RUB160.00M 4
RBV Capital, Unicorn Capital Partners +2
23 Dec 2020
Series A $1.50M 1
RBV Capital
28 May 2019
Seed Round $200.00K -
15 Dec 2017
Seed Round Undisclosed 1
Primer Capital
02 Aug 2017

Botkin.AI Alternatives & Competitors

View All Alternatives
Botkin.AI vs

Translate images into data, discoveries, and diagnoses with deep learning AI for image analysis.

IPO
79 employees
AI, Biotechnology
Botkin.AI vs
Neurabot Lab
Neurabot Lab Indonesia

Neurabot Lab is digital laboratory 4.0 platform and fighting cancer by AI technology in computationa...

Grant
10 employees
AI, Analytics
Botkin.AI vs
CureMetrix
CureMetrix United States

CureMetrix supports the radiologist to improve mammography and save lives.

Series A
43 employees
AI, Biotechnology

FAQ About Botkin.AI

AI-based platform for medical images processing and analysis
Botkin.AI was founded in 2015.
Botkin.AI is headquartered in Moscow, Russia.
Botkin.AI operates in AI and Health Care. Its work centres on AI-based medical imaging, medical image processing, radiology solutions and tumor diagnosis.
Botkin.AI has approximately 10 employees.
Botkin.AI has completed 4 funding rounds, raising a total of $161.70M. The latest funding stage is Series B.
Top alternatives and competitors to Botkin.AI include Aiforia Technologies, Neurabot Lab, CureMetrix, Envisionit Deep AI®, Mindpeak. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Botkin.AI and Aiforia Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Botkin.AI, https://bouncewatch.com/company/botkinai, updated 9 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes